MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration

BACKGROUND: Although there are standard treatment options for osteosarcoma (OS), the prognoses of patients with OS remain varied. Therefore, it is important to profile OS patients at a high risk of mortality to develop focused interventions. Although tumor biomarkers are closely associated with clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xiaotian, Zhang, Qin, Wang, Siyuan, Chen, Xiao, Wang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841137/
https://www.ncbi.nlm.nih.gov/pubmed/34961985
http://dx.doi.org/10.1002/jcla.24214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841137/
https://www.ncbi.nlm.nih.gov/pubmed/34961985
http://dx.doi.org/10.1002/jcla.24214

Ejemplares similares